Shattuck Labs nets $54.9M from 50.6M warrant exercises, extends runway to 2029
STTK•Shattuck Labs has secured notices to exercise approximately 50.6 million warrants, generating aggregate gross proceeds of $54.9 million. Combined with $90.4 million in cash and short-term investments as of March 31, this funding extends the company’s operational runway into 2029.
1. Warrant Exercise Details
Shattuck Labs received notices to exercise approximately 50.6 million common stock warrants, representing about 96% of those issued in its August 4, 2025 private placement. Of these, 5,147,773 warrants were exercised by March 31, and the company expects to realize the remaining 45,438,709 exercises in the current period.
2. Financial Proceeds and Cash Position
The full exercise of warrants is expected to generate aggregate gross proceeds of $54.9 million, including $5.6 million already received by March 31 and an additional $49.3 million forthcoming. As of that date, Shattuck holds $90.4 million in cash and short-term investments.
3. Cash Runway Outlook
With the combined proceeds and existing liquidity, Shattuck Labs projects it can fund its clinical and research operations into 2029 under current plans. This guidance excludes any further capital raises, business development transactions, or incremental clinical development costs beyond these warrants.
